Georges Moarbess

In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives

Georges Moarbess, Carine Deleuze‐Masquéfa, Vanessa Bonnard et al. · Bioorganic & Medicinal Chemistry · 2008 · 116 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Novel and Selective TLR7 Antagonists among the Imidazo[1,2-<i>a</i>]pyrazines, Imidazo[1,5-<i>a</i>]quinoxalines, and Pyrazolo[1,5-<i>a</i>]quinoxalines Series

Nour Bou Karroum, Georges Moarbess, Jean‐François Guichou et al. · Journal of Medicinal Chemistry · 2019 · 50 citations · Full text

Life Sciences, Immunology, Pharmacology +14

New imidazo[1,2-a]quinoxaline derivatives: Synthesis and in vitro activity against human melanoma

Carine Deleuze‐Masquéfa, Georges Moarbess, Sonia Khier et al. · European Journal of Medicinal Chemistry · 2009 · 45 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I–associated adult T-cell leukemia/lymphoma

Georges Moarbess, Hiba El-Hajj, Youmna Kfoury et al. · Blood · 2008 · 38 citations · Full text

Life Sciences, Cell Biology, Oncology +12

New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure–activity relationships

Zahraa Zghaib, Jean‐François Guichou, Johanna Vappiani et al. · Bioorganic & Medicinal Chemistry · 2016 · 34 citations

Medicine, Medicinal Chemistry, Oncology +16